- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
80 Cards in this Set
- Front
- Back
|
Eager to change behavior
Attributes success to their own efforts |
Internal locus of control
|
|
May to difficult to change the behavior
Attribute to luck or fate |
External locus of control
|
|
AHA recommends vigorous activity ______ times a week for _______ minutes
|
3-4 for 30-60 minutes
|
|
Adult learning principle
Intellect, facts and knowledge |
Cognitive
|
|
Adult learning principle
Changing the attitudes or interests towards on object or idea |
Affective
|
|
Adult learning principle
Mastering the physical skills |
Psychomotor
|
|
Identifies the goals and objectives that target changes specific to age, gender, race to improve health of the US over the next decade
|
Healthy People 2010
|
|
Syndrome that deals with HTN and mineralcorticoid disorders
|
Lidell's Syndrome
|
|
Law that deals with electrical changes
|
Ohm's Law
|
|
Volume load on ventricule bwfore contraction
NTG will reduce |
Preload
|
|
Pressure heart has to overcome to eject blood
|
Afterload
|
|
Program cell death
|
Apoptosis
|
|
Thick muscle which can cause arrythmias.
Increase myocardial oxygen demand |
Left Ventricular Hypertrophy
|
|
Effective BP managment, weight reduction, sodium restricition and aerobid exercise are treatment measures for what
|
Left ventricular Hypertrophy
|
|
Clotting factor that increases as a result of smoking
|
Fibrinogen
|
|
Congenital narrowing of the aorta
Characterized by higher pressures in the arms than legs |
Coarctation of the aorta
|
|
Med that reduces peripheral vascular resistance.
Used for Stage 1 HTN |
Thiazides
|
|
Diuretic known for causing gynecomastia due to hormone affects
|
ALdactone/Spironolactone
|
|
Medication that reduces the myocardial oxygen consumption and will decrease the workload of the heart
|
Beta Blocker
|
|
Med used for HTN, HF, MI, DM and protects the lining of the heart vessels
|
ACE inhibitors
|
|
Med that blocks angiotension II receptor site that is used for HTN, DM, MI, HF
|
ARB
|
|
Medication that dilates the peripheral arteries and slows AV conduction time
|
Calcium Channel Blocker
|
|
Med used for Angina, HTN, HF that will cause systemic venous and arterial dilatation
|
Nitrates
|
|
Medication administered only IV and used emergently to reduce afterload and treat HTN
|
Nitroprusside
|
|
Patients with this tend to have morning headaches that clear in 30 minutes due to increased CO2 levels
|
Sleep Apnea
|
|
"Lub"
Closure of mitral and tricuspid valves Systole |
S1
|
|
"dub"
Closure of aortic and pulmonic valves Diastole |
S2
|
|
"kentucky" or "slashing in"
Newly diagnosed patients with Heart Failure tend to have this |
S3
|
|
Tennessee or "a stiff wall"
Pushes extra volume of blood into an already full ventricle |
S4
|
|
You will not hear this extra heart sound in Atrial Fib if the patient has
|
S4
|
|
Friction rub
ST elevation in all leads |
Pericarditis
|
|
Swishing sound over artery
Listen with bell of stethoscope |
Bruit
|
|
Order of assessment
|
Inspect-->palpation--> percuss---> ausculatation
|
|
to do good and prevent harm
|
Beneficence
|
|
Clinician refrain from inflicting harm
|
Non-maleficence
|
|
Tell the truth
Respect privacy If asked, help make decisions |
Autonomy
|
|
Principle of fairness
Do not discriminate |
Justice
|
|
Obligates RN to be truthful with patients and peers
(ie. Disclose errors) |
Veracity
|
|
Behavioral change model that maintains restrictions
(ie. do not look up patients you are not caring for) |
Privacy
|
|
Behavioral change model that has you avoid sharing information
|
Condfidentialty
|
|
Behvioral change model that has faithfulness in keeping a promise
(i.e do not judge person based on thier inability to pay) |
Fidelity
|
|
Not obligatory
< 1% change treatment will be effective |
Quantitative Futility
|
|
Treatment will be effective, but not beneficial
FOr example: PEG placed in CVA patietn will not give patietn back their neuro function |
Qualitative Futility
|
|
Unintentional tort
|
Negligence
|
|
Civil action for financial damages for injury to a person, property or reputation
|
Tort
|
|
Purposeful action to harm
|
Intentional tort
|
|
Human Behavior change theory
Pyramid of survival Motivation of behavior |
Maslows heirarchy of needs
|
|
Human Behavior Theory
Perceived self-efficacy determines the behavior |
Social cognitive theory
|
|
Places the responsibility on individual and why people use disease prevention
|
Health Belief Model
|
|
Focus on helath seeking, rather than disease preventing behaviors
|
Health Promotion Model
|
|
Transtheoretical Model
No intent to change |
precontemplation
|
|
Transtheoretical Model
Acknowledges the need to change but is ambivalent |
Contemplation
|
|
Transtheoretical Model
Begins to explore ways to change, usually within the next month |
Preparation
|
|
Transtheoretical Model
Changes the behavior |
action
|
|
Transtheoretical Model
Continues to change, but can relapse |
Maintenance
|
|
Transtheoretical Model
Revise self image and former dehavior is no longer a threat |
Termination
|
|
Leadership Style
Uses power to influence group |
Autocratic
|
|
Leadership Style
Uses democratic process to encourage participation of members |
Partcipative
|
|
Leadership Style
Minimal guidance and little feedback/does not like change |
Laissez-Faire
|
|
Leadership Style
Status quo/only deals with problems as they occur |
Transactional
|
|
Leadership Style
Has a vision and commitment to organizational goals |
Transformational
|
|
Expressed in words, not numbers
Gain insight through meaning |
QUalitative methods
|
|
Variables and numbers
|
Quantative Methods
|
|
Researcher concludes that there is a difference, when there really is not
|
Type 1 Error
|
|
Researcher concludes that there is NOT a difference, when in fact there is
|
Type 2 Error
|
|
Blockage surrounds all parts of the intimal layer
|
Concentric Lesion
|
|
Blockage surrounds a portion of the intimal layer
|
Eccentric Lesion
|
|
#1 modifiable risk factor
|
Smoking
|
|
Ask, Advise, Assess, Assist, Arrange
|
5 As to Quitting smoking
|
|
If patient is on 2 anti-HTN meds, it is recommended to perform what test
|
Sleep study
|
|
Inflammatory marker associated with CVD and stroke
|
Hs-CRP
|
|
Endothelial toxin that is treated with Folate and Vitamin B
|
Homocysteine
|
|
May inhibit fibrinolysis,
Function is unknown Treat with niacin |
Lipoprotein (a)
|
|
These cholesterol levels are often elevated in DM, Obesity and alcoholics
|
Triglycerides
|
|
Those patients without the disease. Motivate the patients to adhere to risk reduction strategies
|
Primary Prevention
|
|
Aggressive treatment of all modifiable risks/ already have the disease
|
Secondary prevention
|
|
SBP 120-139
DBP 80-89 |
Prehyertension
|
|
SBp 140-159
DBP 90-99 Treatment= Thiazide |
Stage 1 HTN
|
|
SBP > 160
DBP > 100 Treatment= 2 drug combo |
Stage 2 HTN
|
|
This diet is high in potassium and low in sodium and used to treat HTN
|
DASH
|